These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
626 related articles for article (PubMed ID: 21054236)
21. In vitro investigation of efficacy of new reactivators on OPC inhibited rat brain acetylcholinesterase. Atanasov VN; Petrova I; Dishovsky C Chem Biol Interact; 2013 Mar; 203(1):139-43. PubMed ID: 23220589 [TBL] [Abstract][Full Text] [Related]
22. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice. Kassa J; Karasova JZ; Pavlikova R; Misik J; Caisberger F; Bajgar J J Appl Toxicol; 2010 Mar; 30(2):120-4. PubMed ID: 19746406 [TBL] [Abstract][Full Text] [Related]
23. Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship? Aurbek N; Herkert NM; Koller M; Thiermann H; Worek F Chem Biol Interact; 2010 Sep; 187(1-3):215-9. PubMed ID: 20105433 [TBL] [Abstract][Full Text] [Related]
24. Syntheses and in vitro evaluations of uncharged reactivators for human acetylcholinesterase inhibited by organophosphorus nerve agents. Renou J; Mercey G; Verdelet T; Păunescu E; Gillon E; Arboléas M; Loiodice M; Kliachyna M; Baati R; Nachon F; Jean L; Renard PY Chem Biol Interact; 2013 Mar; 203(1):81-4. PubMed ID: 23111374 [TBL] [Abstract][Full Text] [Related]
25. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned rats. Kassa J; Jun D; Karasova J; Bajgar J; Kuca K Chem Biol Interact; 2008 Sep; 175(1-3):425-7. PubMed ID: 18547554 [TBL] [Abstract][Full Text] [Related]
26. [Comparison of the reactivation effects of the HI-6 oxime and obidoximeon cyclosin-inhibited acetylcholinesterase in the diaphragm and various parts of the brain in rats]. Kassa J Ceska Slov Farm; 1998 Feb; 47(1):47-50. PubMed ID: 9600150 [TBL] [Abstract][Full Text] [Related]
27. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds. Maxwell DM; Brecht KM; Sweeney RE Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773 [TBL] [Abstract][Full Text] [Related]
28. A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M Acta Medica (Hradec Kralove); 2005; 48(2):81-6. PubMed ID: 16259317 [TBL] [Abstract][Full Text] [Related]
29. Comparison of in vitro potency of oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited acetylcholinesterase in various parts of pig brain. Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M J Appl Toxicol; 2005; 25(4):271-6. PubMed ID: 16021679 [TBL] [Abstract][Full Text] [Related]
30. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study. Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253 [TBL] [Abstract][Full Text] [Related]
31. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats. Kassa J; Jun D; Kuca K J Enzyme Inhib Med Chem; 2007 Jun; 22(3):297-300. PubMed ID: 17674811 [TBL] [Abstract][Full Text] [Related]
32. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning. Lucić Vrdoljak A; Calić M; Radić B; Berend S; Jun D; Kuca K; Kovarik Z Toxicology; 2006 Nov; 228(1):41-50. PubMed ID: 16982122 [TBL] [Abstract][Full Text] [Related]
33. A comparison of the reactivating and therapeutic efficacy of newly developed oximes (K347, K628) with commonly used oximes (obidoxime, HI-6) against tabun in rats and mice. Kassa J; Karasova JZ; Kuca K; Musilek K Drug Chem Toxicol; 2010 Jul; 33(3):227-32. PubMed ID: 20429807 [TBL] [Abstract][Full Text] [Related]
34. In silico pharmacophore model for tabun-inhibited acetylcholinesterase reactivators: a study of their stereoelectronic properties. Bhattacharjee AK; Kuca K; Musilek K; Gordon RK Chem Res Toxicol; 2010 Jan; 23(1):26-36. PubMed ID: 20028185 [TBL] [Abstract][Full Text] [Related]
35. Changes of rat plasma total low molecular weight antioxidant level after tabun exposure and consequent treatment by acetylcholinesterase reactivators. Pohanka M; Karasova JZ; Musilek K; Kuca K; Jung YS; Kassa J J Enzyme Inhib Med Chem; 2011 Feb; 26(1):93-7. PubMed ID: 20569082 [TBL] [Abstract][Full Text] [Related]
36. A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice. Kassa J; Sepsova V; Matouskova L; Horova A; Musilek K Toxicol Mech Methods; 2015 Mar; 25(3):229-33. PubMed ID: 25894563 [TBL] [Abstract][Full Text] [Related]
37. Reactivation of nerve agent-inhibited human acetylcholinesterase by obidoxime, HI-6 and obidoxime+HI-6: Kinetic in vitro study with simulated nerve agent toxicokinetics and oxime pharmacokinetics. Worek F; Koller M; Thiermann H; Wille T Toxicology; 2016 Mar; 350-352():25-30. PubMed ID: 27153754 [TBL] [Abstract][Full Text] [Related]
38. Comparison of reactivating and therapeutic efficacy of two salts of the oxime HI-6 against tabun, soman and cyclosarin in rats. Kassa J; Jun D; Kuca K; Bajgar J Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):328-32. PubMed ID: 17910616 [TBL] [Abstract][Full Text] [Related]
39. Comparison of the efficacy of HI-6 and obidoxime against cyclohexyl methylphosphonofluoridate (GF) in rats. Kassa J; Bajgar J Hum Exp Toxicol; 1995 Nov; 14(11):923-8. PubMed ID: 8588955 [TBL] [Abstract][Full Text] [Related]
40. Oximes: Reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning. Kovarik Z; Calić M; Sinko G; Bosak A; Berend S; Vrdoljak AL; Radić B Chem Biol Interact; 2008 Sep; 175(1-3):173-9. PubMed ID: 18501341 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]